Results 261 to 270 of about 328,521 (340)
Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa
Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 2, Page 233-241, August 2025.ABSTRACT Objective
To describe the clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa. Methods
This was a retrospective international multicenter study. Using the International Ovarian Tumor Analysis (IOTA) database, patients with a histological diagnosis of serous or mucinous cystadenoma who had undergone ...F. Mascilini, F. Moro, T. Pasciuto, P. Sladkevicius, W. Froyman, L. Jokubkiene, C. Van Holsbeke, D. Franchi, E. Epstein, S. Guerriero, V. Chiappa, F. Buonomo, M. J. Kudla, J. L. Alcázar, L. Hochberg, F. Ciccarone, L. Quagliozzi, G. Scambia, D. Timmerman, L. Valentin, A. C. Testa +20 morewiley +1 more sourceIncreased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer. [PDF]
J Mol Med (Berl)Frühbeck G, Criado S, Gómez-Ambrosi J, Ramírez B, Becerril S, Rodríguez A, Neira G, Salmón-Gómez L, Valentí V, Moncada R, Baixauli J, Silva C, Catalán V. +12 moreeuropepmc +1 more sourceLong‐term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment
BJU International, Volume 136, Issue 2, Page 245-253, August 2025.Objectives
To present the long‐term outcomes of men with Grade Group (GG) 1 prostate cancer (PCa), included in the Prostate Cancer Research International Active Surveillance (PRIAS) study, and to assess the effect of the inclusion of magnetic resonance imaging (MRI) within the active surveillance (AS) protocol. Patients and Methods
The PRIAS study is a Ivo I. de Vos, Cristina Marenghi, Fabio Badenchini, Egbert R. Boevé, Francisco Lozano‐Uruñuela, Markus Graefen, Antti S. Rannikko, Frederic Staerman, Mikio Sugimoto, Takuma Kato, Diederik M. Somford, Mark Frydenberg, Chris H. Bangma, Sebastiaan Remmers, Monique J. Roobol, Prostate Cancer Research International: Active Surveillance (PRIAS) consortium, E. Planken, J. Jaspars, V. Berge, O.A. Hopland, R. Raaijmakers, G. Smits, J. van Brakel, D. van der Schoot, T. Habuchi, H. van der Poel, P. de Vries, A. Clarke, M. Kummeling, S. Dijkstra, J. de Baaijt, W. Scheepens, A. Villers, O. Capoun, T. Ichikawa, S. Sakamoto, R. Gregoir, B. Guillonneau, K. van Dalen, A. Jungwirth, N. Azevedo, T. Dellavedova, F. Sanguedolce, P. P. Pérez, M. Maffezzini, M. Kortleve, M. Eto, K. Suzuki, H. Roshani, T. Sugiyama, K. Shiga, D. Caasen‐Findeisen, J. Schmitges, J. Teishima, S. Maruyama, I. Parra, P. F. Martinez, J.M.C. Giné, R Bastus, E.R. Barselo, F.J.P. García, M. Montesino, B. Rikken, W. Obara, R.A. Schipper, H. Sasaki, Y. Kakehi, T. Matsuda, H. Kinoshita, K. Tabata, M. Schiffer, J. Winkle, T.A. Ozkan, N. Schmeller, S. Aaltomaa, Y. Yamamoto, A. Terai, M. Multanen, H. Fukuhara, O. Ukimura, T. Inoue, A. Yokomizo, J.M. Alapont‐Alacreu, R. Pelger, E. van Gennep, S. Klaver, K. Tully, S. Knipper, R. Sosnowski, M. Schotman, J. Verlind, B. Santerse, M.J. Pit, N. Hendolin, N. Terada, T. Hakariya, H. Okuno, L.W. Tim, Y. Kitamura, Y. Tomita, R. Bosshardt, M. Nakayama, M. Uemura, M. Vaarala, I. Taina, G. Rodemer, C.F. Ng, P. Chiu, S. Laabs, J. Hoeven, N. Bosch, S. Saito, Y. Sakai, K. Hashimoto, M. Leskinen, K. Hashine, A. Paganelli, A. Lapini, E. Trenti, M. Roscigno, M. Tanello, M.A. Alvisi, N. Lo Iacono, G. Simone, O. Caffo, G. Cicchetti, G. Conti, R. Sanseverino, P. Ditonno, G. Martorana, P. Verze, A. Geboers, A.N. Noordzij, A. Sonneveld, J. Beck, S. van Selm, M.B. Busstra, D. van Diepen, M. Landman, E. A. Treiyer, T. Anagnostou, M. Gillich, J. Hanske, Y. Naya, F. van der Windt, K. Kawashima, N. Kamiya, K. Mitsuka, T. Nomoto, K. Akakura, J. Iizuka, B. Wijsman, I. van Oort, P. Papavassilis, A. Semjonow, N. Mottet, F. G. Veiga, A. Bjartell, J. Serrano Uribe, H. Fukuhara, M. Nakamura, T. Keul, H. Hollberg, T. Dill, I. Kaspers, Z. Türk, J. Lehmann, M. Ruhs, C. Hawke, M. Rice, D. Gyomber, N. Lawrentschuk, L. Johns‐Putra, H. F. Chan, F. Macneil, M. Louie‐Johnsun, P. Anderson, K. Rantall, P. Ruljancich, A. Jayathillake, C. Chemasle, S. La Bianca, D. Murphy, M.J. Monsour, A. Vega, C. Smiles, D. Malouf, J. Grummet, M. Patel, V. Chalasani, P. Rashid, S. Brough, A. Tan, U. Behrendt, M. de Bruin‐Titulaer, A.N. Vis, I. Hara, M. Leter, N. Tsuchiya, H. Matsumoto, I. Proost, A.Q.H.J. Niemer, E.B. Cornel +202 morewiley +1 more sourceTargeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas. [PDF]
Cell Rep MedLabiano S, Marco-Sanz J, Ausejo-Mauleon I, Laspidea V, Hernández-Osuna R, Garcia-Moure M, Nava D, Nuin S, Gonzalez-Huarriz M, Phoenix TN, Tamayo I, Zalacain M, Lacalle A, Marrodan L, Puigdelloses M, Hervás-Corpión I, Ochoa MC, Casares N, Becher OJ, Gomez-Manzano C, Fueyo J, Perez-Larraya JG, Patiño-Garcia A, Alonso MM. +23 moreeuropepmc +1 more sourceCellular composition and transcriptomics of subcutaneous adipose tissue linked to blood glycated haemoglobin
European Journal of Clinical Investigation, Volume 55, Issue 8, August 2025.Immune cell overrepresentation in SAT in subjects with high HbA1c was accompanied by decreased adipocytes, smooth muscle, pericytes and other endothelial cell numbers. Immune system and inflammation‐related pathways, cellular senescence and telomere‐related pathways, nervous system development and extracellular matrix organization were associated with ...Sara Paulí, Núria Oliveras‐Cañellas, José Maria Moreno‐Navarrete, Anna Castells‐Nobau, Francisco José Ortega, Jose Ignacio Rodriguez‐Hermosa, Ernesto Castro, Birong Zhang, You Zhou, Javier Gómez‐Ambrosi, Ana Belén Crujeiras, Oriol Alberto Rangel‐Zuñiga, Lourdes Garrido‐Sanchez, Sara Becerril, María Pardo, Juan Luis Romero‐Cabrera, Carolina Gutierrez‐Repiso, Marcos C. Carreira, Manuel Macias‐Gonzalez, Miguel Ángel Martinez‐Olmos, Gema Frühbeck, Luisa Maria Seoane, José López‐Miranda, Francisco José Tinahones, Carlos Diéguez, Jordi Mayneris‐Perxachs, José Manuel Fernández‐Real +26 morewiley +1 more source
